Research Overview of Droste-Med 150mg
Droste-Med 150mg is a synthetic androgenic-anabolic steroid derivative containing drostanolone propionate as the active pharmaceutical ingredient. Developed by Bioniche Pharma for scientific research applications, this compound allows researchers to investigate the molecular mechanisms of selective androgen receptor modulation in laboratory settings. The 150mg concentration provides consistent dosing parameters for controlled experimental protocols, enabling researchers at Stroid UK Shop to conduct comprehensive studies on androgenic pathway interactions.
Laboratory Applications in Research
Research scientists utilise Droste-Med 150mg to examine protein synthesis pathways and investigate cellular responses to androgenic stimulation in vitro. The compound’s unique molecular structure enables detailed analysis of receptor binding affinity and downstream signalling cascades. Comparative studies often evaluate this research chemical alongside compounds from our drostanolone propionate collection to understand structural-activity relationships. Advanced research protocols may incorporate additional compounds such as selective androgen receptor modulators or peptide compounds to examine synergistic molecular interactions under controlled laboratory conditions.
Chemical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Drostanolone Propionate |
| Concentration | 150mg/ml |
| Manufacturer | Bioniche Pharma |
| Molecular Formula | C23H36O3 |
| Molecular Weight | 360.53 g/mol |
| CAS Number | 521-12-0 |
| Storage Temperature | Room Temperature |
| Purity | Verify with supplier |
Research Compliance Statement
Droste-Med 150mg Bioniche Pharma is manufactured exclusively for in-vitro laboratory research applications and scientific investigation purposes. This product is not intended for human consumption, clinical use, or any application outside controlled laboratory environments. Researchers must ensure appropriate laboratory protocols, safety measures, and regulatory compliance when conducting studies with this research chemical. All experimental work should be performed by qualified personnel in properly equipped research facilities.
